In less than three months, a major change in telemarketing compliance will take effect, impacting law firms and legal marketing teams across the nation. On January 27, 2025, the FCC’s 1:1 Consent Rule will officially go into effect, requiring significant changes...
Intake
Depo-Provera Lawsuit: A New Frontier in Mass Tort Litigation
As the legal landscape shifts in response to growing concerns over the birth control injection Depo-Provera, law firms are seeing a rise in claims from injured patients. Manufactured by Pfizer, Depo-Provera has been linked to severe side effects such as osteoporosis...
Mastering Mass Torts: True Costs, Feedback Loops, and Vendor Relationships
Mass tort litigation is one of the most challenging and high-stakes areas of legal practice. It involves coordinating thousands of plaintiffs and navigating the complexities of case acquisition, case development, and settlement negotiations. Devin Downey, co-founder...
AI is Taking Over Some Call Centers—But Here’s Why Human Intake Will Keep Crushing It in Mass Tort and Personal Injury
There’s no denying it: artificial intelligence is shaking up industries left and right, and legal intake is no exception. With podcasts like All-In declaring that AI will wipe out call centers in the next few years, it’s easy to get swept up in the idea that...
How $100 Million in Class Action Settlement Fraud Is Shaking Up the Legal Industry
The Intersection of Performance Media, Class Action Settlement Fraud, and Legal Tech The rise of performance media has transformed many industries, including legal marketing and class action settlements. However, it has also introduced significant challenges,...
Potential Vision Loss Linked to Novo’s Semaglutide used in Ozempic and Wegovy
Summary of Key Findings- Study Association: Harvard University study suggests a potential link between Novo Nordisk’s semaglutide (Ozempic and Wegovy) and nonarteritic anterior ischemic optic neuropathy (NAION).- Increased Risk: Semaglutide users were found to be four...